FGP
TMO icon

Freestone Grove Partners’s Thermo Fisher Scientific TMO Stock Holding History

Freestone Grove Partners’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$113M Buy
+226,238
New +$109M 0.73% 21
2025
Q4 		– Sell
-170,124
Closed -$82.5M – 946
2025
Q3 		$82.5M Buy
+170,124
New +$79.2M 0.62% 29

Other funds holding TMO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Freestone Grove Partners's TMO Position: Q2 2026 in Review

Freestone Grove Partners opened a new position in Thermo Fisher Scientific (TMO) in Q2 2026: 226,238 shares worth $113M. The stake represents 0.73% of the portfolio and ranks #21 among its holdings. This is a return to the name: Freestone Grove Partners previously reported a position in TMO as recently as Q3 2025.

Freestone Grove Partners first reported a position in TMO in Q3 2025 and has held it in 2 quarters since. 2,609 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • Freestone Grove Partners held 226,238 shares of Thermo Fisher Scientific worth $113M as of Q2 2026.
  • Thermo Fisher Scientific was a new Freestone Grove Partners position in Q2 2026.
  • Thermo Fisher Scientific made up 0.73% of Freestone Grove Partners's portfolio in Q2 2026, its #21 holding.
  • Freestone Grove Partners first reported a position in Thermo Fisher Scientific in Q3 2025 and has held it in 2 quarters since.
  • 2,609 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Freestone Grove Partners's 13F filing for Q2 2026, filed 14 Aug 2026.